Researchers developed a machine learning model to proactively identify cancer patients at high risk of financial stress from treatment.
Key Details
- 1Study used data from 793 cancer patients undergoing or recently completing treatment.
- 2Six machine learning models were tested; best achieved 84% sensitivity and 75% specificity.
- 3Key predictors included younger age, lower income, poorer health, active treatment, and higher out-of-pocket costs.
- 4A web-based calculator was developed for clinical use to estimate individual financial toxicity risk.
- 5The tool aims to shift financial toxicity screening from reactive to proactive, connecting patients with support earlier.
Why It Matters
Early identification of financial toxicity risk could allow healthcare teams to intervene before financial burdens affect cancer treatment adherence or outcomes. The study demonstrates a practical AI application that supports better patient care and resource allocation, a principle translatable to radiology and imaging AI contexts.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.